Baillie Gifford & Co’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.5M | Sell |
|
|||||
|
2025
Q1 | $25M | Sell |
|
|||||
|
2024
Q4 | $35.9M | Sell |
|
|||||
|
2024
Q3 | $33.5M | Sell |
|
|||||
|
2024
Q2 | $64.9M | Sell |
|
|||||
|
2024
Q1 | $105M | Sell |
|
|||||
|
2023
Q4 | $137M | Sell |
|
|||||
|
2023
Q3 | $121M | Sell |
|
|||||
|
2023
Q2 | $170M | Buy |
|
|||||
|
2023
Q1 | $150M | Buy |
|
|||||
|
2022
Q4 | $200M | Buy |
|
|||||
|
2022
Q3 | $132M | Buy |
|
|||||
|
2022
Q2 | $142M | Buy |
|
|||||
|
2022
Q1 | $108M | Buy |
|
|||||
|
2021
Q4 | $51.1M | Buy |
|
|||||
|
2021
Q3 | $64.9M | Buy |
|
|||||
|
2021
Q2 | $60M | Buy |
|
|||||
|
2021
Q1 | $39.2M | Buy |
|